Related Experiment Videos
Immunological changes in opportunistic parasitic infections
H M Khalil1, M K Makled, M E Azab
1Department of Parasitology, Faculty of Medicine, Ain Shams University, Egypt.
Journal of the Egyptian Society of Parasitology
|April 1, 1991
Summary
Cancer patients exhibit weakened cell-mediated immunity, further compromised by parasitic infections. Opportunistic and mixed parasitic infections significantly worsen immune suppression in cancer patients.
Area of Science:
- Immunology
- Oncology
- Infectious Diseases
Background:
- Malignant diseases can impact the immune system.
- Parasitic infections, particularly opportunistic ones, may further complicate cancer progression.
- Understanding the interplay between cancer, parasitic infections, and immune status is crucial.
Purpose of the Study:
- To investigate the immunological status of cancer patients with varying parasitic infection types.
- To assess the impact of opportunistic and non-opportunistic parasitic infections on cell-mediated and humoral immunity in cancer patients.
Main Methods:
- Studied 110 cancer patients and 20 healthy controls, categorized into four groups based on parasitic infection status.
- Assessed cell-mediated immunity using the leucocyte migration inhibition test and intradermal skin test.
- Evaluated humoral immunity through quantitative determination of immunoglobulins (IgG, IgM, IgA).
Main Results:
- Cell-mediated immunity was reduced in cancer patients compared to controls.
- Parasitic infections, especially opportunistic and mixed types, led to a more pronounced decrease in cell-mediated immunity.
- Immunoglobulin levels varied: IgG and IgA increased in non-mixed infection groups but decreased in the mixed group; IgM increased in non-infected and non-opportunistic groups but decreased with opportunistic infections.
Conclusions:
- Cancer is associated with impaired cell-mediated immunity.
- Superimposed parasitic infections exacerbate immune deficiency in cancer patients.
- Opportunistic and mixed parasitic infections significantly suppress cell-mediated immunity and alter immunoglobulin profiles in cancer patients.